I doubt Pozen will discuss earnings other than to reiterate the $20 million milestone payment from AZN. They just held a conference on Thursday to discuss their earnings and the only change is the FDA approval of VIMOVO. However, it might be possible they state their projected ernings for this quarter and year but even that is doubtful as the future earnings are still subject to VIMOVO approval in outside US areas.
Is POZN discussing the earnings too... guess so? i am not sure...